Michael Hill explains how the system works when a patient's blood glucose drops.
Read More »Transcript: Dr. Richard Bergenstal
In this Exclusive Interview transcript, Dr. Richard Bergenstal discusses the first approval of a hybrid closed-loop system and the future of diabetes treatment, including a possible cure for type 1 diabetes.
Read More »Video: Dr. Richard Bergenstal
In this Exclusive Interview, Dr. Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the technology in the artificial pancreas, the new Abbott Libre CGMS, and the possible diabetes cure.
Read More »CGM Will Change The Way We Treat Type 1 And Type 2 Diabetes
Let’s start off with what is in the pipeline.
Read More »When Patients Change Insulin Pumps, Beware! Changes May Occur
Woman, 53 years of age, type 1 diabetes, has been wearing an insulin pump for 18 years. Recently changed insulin pumps. Not only upgraded on a certain brand, but now has a totally different brand. We did not change settings when she started with her new pump. She called to let me know her glucose levels were higher since she has her new pump.
Read More »The Most Common Hassle For Type 1 Diabetes Patients
Barrier means more work including monitoring more often and making more adjustments.
Read More »Beta Bionics Reaches a Milestone
Recently Beta Bionics, the makers of the iLet artificial pancreas, reached a significant milestone: raising $1 million through online public fundraising. It is no longer a question of if an artificial pancreas will exist, but of when it will become commercially available. With every major insulin pump company working in this area, along with many startups, patients will not just have one system, but several they can chose from.
Read More »The Use of Technology in Medical Practice
How do consumers and HCPs feel about new technologies and their impact on our health system?
Read More »How Will CGM’s Success Impact Conventional Glucose Monitors?
Guest Post by David Kliff, Diabetic Investor
The FDA approved Dexcom’s request for a non-adjunctive claim this week. It looks like a bad situation for conventional glucose monitors, and believe it or not is about to get worse. Here’s why.
Will 2017 Bring Us the First Artificial Pancreas for Type 1 Diabetes?
System shows significant improvement in HbA1c compared to current best therapy available.
Read More »